Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics Publication Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics Certara2017 年 7 月 1 日
Time Dependent Pharmacokinetics of Pembrolizumab in Patients with Solid Tumor and Its Correlation with Best Overall Response Publication Time Dependent Pharmacokinetics of Pembrolizumab in Patients with Solid Tumor and Its Correlation with Best Overall Response Certara2017 年 6 月 1 日
Obeticholic Acid—From PK Model to Drug Label On-Demand Webinar Obeticholic Acid—From PK Model to Drug Label Watch this webinar with Jeffrey Edwards to learn how he used physiologic pharmacokinetic modeling to…Certara2017 年 6 月 1 日
Using Pharmacokinetics to Assure Chemical Food Safety Blog Using Pharmacokinetics to Assure Chemical Food Safety As a veterinarian, I’m responsible for the health and welfare of my animal patients. Sometimes,…Certara2017 年 5 月 12 日
Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Publication Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications Certara2017 年 5 月 1 日
Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats Publication Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats Certara2017 年 5 月 1 日
Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation Publication Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation Certara2017 年 4 月 1 日
The Model-informed Precision Dosing Revolution Is Coming Blog The Model-informed Precision Dosing Revolution Is Coming Modeling and simulation (M&S) has been widely accepted and adopted by biopharmaceutical companies and global…Certara2017 年 3 月 7 日
CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites Publication CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites Certara2017 年 3 月 1 日
A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor Publication A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor Certara2017 年 1 月 10 日